How should the levothyroxine (Eltroxin) dose be adjusted in an infant with congenital hypothyroidism who has elevated T4 and suppressed TSH after receiving 50 µg daily?

Elevated T4 and Suppressed TSH After Levothyroxine Treatment in Congenital Hypothyroidism

Do not reduce the levothyroxine dose based on a single elevated T4 measurement, but if TSH remains suppressed (<0.05 mU/L) with persistently elevated T4 on repeat testing, reduce the dose by approximately 20-30% and recheck thyroid function in 2 weeks. 1

Understanding the Clinical Picture

This presentation suggests iatrogenic overtreatment, which occurs in approximately 36-57% of infants started on higher levothyroxine doses (>12.5 µg/kg/day) 2. The 50 µg dose you mention likely represents 12-15 µg/kg/day for a typical newborn, placing this infant at the higher end of the recommended dosing range.

Key Management Principles

Do NOT Act on Single Measurements

• The European Society for Paediatric Endocrinology explicitly states that dose reductions should not be based on a single elevated FT4 concentration 1
• Ensure blood was drawn at least 4 hours after the last levothyroxine dose to avoid falsely elevated levels 1

Target Ranges During Treatment

The goal is to maintain:

• TSH in the age-specific reference range (but avoid undetectable TSH <0.05 mU/L)
• T4/FT4 in the upper half of the age-specific reference range 1

When to Adjust the Dose

If confirmed overtreatment (repeat testing shows):

• Very low/suppressed TSH (<0.05 mU/L) AND
• Elevated T4 above the upper reference range

Then reduce the dose by 20-30% and recheck in 2 weeks 1

Critical Timing Considerations

The timing of follow-up depends on the infant's age:

• First 2 weeks of life: Check every 1-2 weeks until TSH normalizes 1
• Until 12 months: Check every 2 weeks until TSH completely normalized, then every 1-3 months 1
• After any dose change: Recheck in 4-6 weeks 1

Common Pitfalls to Avoid

1. Overreacting to a single lab value: This is the most common error. Repeat testing is essential 1

2. Timing of blood draw: If drawn within 4 hours of levothyroxine administration, T4 will be artificially elevated 1

3. Confusing transient elevation with true overtreatment: Some infants show temporary T4 elevation that self-corrects without dose adjustment

4. Reducing dose too aggressively: A 20-30% reduction is appropriate; larger reductions risk undertreatment 1

Consider Re-evaluation of Diagnosis

If the infant shows persistent suppressed TSH with high T4 despite dose reductions, consider whether this represents true permanent congenital hypothyroidism versus transient hypothyroidism 1. Re-evaluation can be performed by:

• Decreasing the dose by 30% for 2-3 weeks and rechecking
• If TSH rises to ≥10 mU/L, permanent CH is confirmed
• If TSH remains normal, consider further dose reduction with retesting 1

The Neurodevelopmental Context

While overtreatment carries risks, the primary concern in CH management is preventing undertreatment during the critical first 2-3 years of brain development 1, 3, 4. Studies show that infants with severe CH (athyreosis, very low initial T4) who received higher doses had better TSH normalization, though some required dose adjustments for overtreatment 2, 5. The key is achieving rapid TSH normalization while avoiding sustained suppression.

Bottom line: Repeat the thyroid function tests before making any changes. If overtreatment is confirmed on repeat testing, reduce the dose by 20-30% rather than making dramatic changes, and maintain close follow-up every 2 weeks until stable.